Law360 reports (subscription) that Johnson & Johnson received a $70 million verdict on a Philadelphia Risperdal injury case where side effectsd of the widely-prescribed antipsychotic drug caused an adolescent boy to grow prominent breasts. This verdict is significantly higher than other recent Pennsylvania Risperdal injury judgments against J&T over allegations that the drug caused breast growth. [Read more…]
A Philadelphia jury returned a $2.5 million verdict against healthcare giant Johnson & Johnson for a 20-year-old autistic man from Alabama who allegedly developed large breasts as a teenager while prescribed the antipsychotic medication Risperdal. The lawsuit charged that Johnson & Johnson failed to warn consumers of the distressing side effects that Risperdal causes, concealing from officials the dangerous and defective risks involved when taking the prescribed medication.
Attorney Wendy R. Fleishman of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, announced that four young men prescribed the antipsychotic medication Risperdal recently filed separate personal injury lawsuits alleging that Risperdal is a defective and dangerous prescription drug. The complaints were brought against Johnson & Johnson and its subsidiary Janssen Pharmaceuticals, the manufacturer of Risperdal, in state court in Pennsylvania, where Janssen Pharmaceuticals is located. [Read more…]